INDIANA BLOODWORX
Live / Applied — Statement of use — registration review complete (as of 26 Sept 2026)
What this means for you
Not registered yet, but its 25 Aug 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97564892
- Mark type
- Word mark
- Filed
- 25 Aug 2022
- Published for opposition
- 09 Jan 2024
- Attorney of record
- Thomas A. Walsh
Goods and services
- Class 036 — Insurance and financial services: Financial administration of reimbursement programs for pharmaceutical services
Owner
- Indiana Hemophilia and Thrombosis Center, Inc., Indianapolis, IN, US
- Indiana Hemophilia and Thrombosis Center, Inc., Indianapolis, IN, US
Prosecution history
- 26 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Feb 2025 — USE AMENDMENT FILED
- 21 Feb 2025 — SOU EXTENSION 2 GRANTED
- 20 Feb 2025 — SOU EXTENSION 2 FILED
- 22 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Feb 2025 — TEAS STATEMENT OF USE RECEIVED
- 15 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Nov 2024 — SOU EXTENSION 1 GRANTED
- 16 Aug 2024 — SOU EXTENSION 1 FILED
- 15 Nov 2024 — DIVISIONAL PROCESSING COMPLETE
- 16 Aug 2024 — DIVISIONAL REQUEST RECEIVED